Bainey Kevin R, Fu Yuling, Wagner Galen S, Goodman Shaun G, Ross Allan, Granger Christopher B, Van de Werf Frans, Armstrong Paul W
University of Alberta, Edmonton, Alberta, Canada.
Am Heart J. 2008 Aug;156(2):248-55. doi: 10.1016/j.ahj.2008.03.018. Epub 2008 Jun 11.
Spontaneous reperfusion (SR) in ST-elevation myocardial infarction has traditionally been assessed by coronary angiography. The frequency of SR varies widely in prior studies, and the clinical implications in the modern reperfusion era are unclear. Accordingly, using data from the ASSENT 4 PCI (ASsessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) study, we undertook a systematic assessment of SR using both electrocardiographic (ECG) and angiographic techniques.
Five hundred eighty-five patients randomized to the primary percutaneous coronary intervention (PCI) arm of ASSENT 4 PCI were studied: all had ECG and thrombolysis in myocardial infarction flow data available approximately 60 minutes after randomization and before PCI. Electrocardiographic SR (>/=70% ST-segment resolution) occurred in 14.9% (87/585) and angiographic SR (thrombolysis in myocardial infarction grade 3) in 14.7% (86/585) of patients. Thirty-day clinical outcomes of patients with ECG SR versus no ECG SR tended to have lower mortality (0% vs 3.4%, P = .091), a lower composite of death/shock/congestive heart failure (6.9% vs 12.2%, P = .148), and significant reductions in death/reinfarction (0% vs 5.6%, P = .014). By contrast, no such differences were evident in patients with angiographic SR versus no SR for death (2.3% vs 3.0%, P = 1.00), death/shock/congestive heart failure (9.3% vs 11.8%, P = .498), or death/reinfarction (2.3% vs 5.2%, P = .409).
Whereas the frequency of SR was comparable using either ECG or angiographic criteria, clinical outcomes were best aligned with ECG SR. These data support the role of the ECG in assessing reperfusion and likely reflect the overall impact of myocardial perfusion versus infarct-related artery epicardial patency alone.
传统上,ST段抬高型心肌梗死的自发再灌注(SR)是通过冠状动脉造影来评估的。在以往的研究中,SR的发生率差异很大,在现代再灌注时代其临床意义尚不清楚。因此,我们利用ASSENT 4 PCI(经皮冠状动脉介入治疗新治疗策略的安全性和有效性评估)研究的数据,采用心电图(ECG)和血管造影技术对SR进行了系统评估。
对随机分配至ASSENT 4 PCI主要经皮冠状动脉介入治疗(PCI)组的585例患者进行了研究:所有患者在随机分组后约60分钟且在PCI术前均有ECG和心肌梗死溶栓血流数据。心电图SR(ST段回落≥70%)发生在14.9%(87/585)的患者中,血管造影SR(心肌梗死溶栓3级)发生在14.7%(86/585)的患者中。有心电图SR的患者与无心电图SR的患者相比,30天临床结局倾向于有更低的死亡率(0%对3.4%,P = 0.091)、更低的死亡/休克/充血性心力衰竭复合终点(6.9%对12.2%,P = 0.148)以及死亡/再梗死的显著降低(0%对5.6%,P = 0.014)。相比之下,有血管造影SR的患者与无SR的患者在死亡(2.3%对3.0%,P = 1.00)、死亡/休克/充血性心力衰竭(9.3%对11.8%,P = 0.498)或死亡/再梗死(2.3%对5.2%,P = 0.409)方面没有明显差异。
虽然使用心电图或血管造影标准时SR的发生率相当,但临床结局与心电图SR最为一致。这些数据支持了心电图在评估再灌注中的作用,并且可能反映了心肌灌注与仅梗死相关动脉心外膜通畅的总体影响。